# Tissue Collection for Biomarkers Determining Resistance to Ibrutinib

> **NCT02267590** · — · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 120 (estimated)

## Conditions studied

- Mantle Cell Lymphoma
- Chronic Lymphocytic Leukaemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02267590
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2014-10-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02267590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02267590, "Tissue Collection for Biomarkers Determining Resistance to Ibrutinib". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02267590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*